Entrada Shares Climb After FDA Removes Hold on Muscular Dystrophy Treatment
Shares of Entrada Therapeutics rose after regulators removed a clinical hold and said its lead product candidate could be studied as a treatment for Duchenne muscular dystrophy. The stock was up 9.5% ...
Precision BioSciences Announces Oral Presentation at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® ...
KIMT22h
Minnesota teachers called to enter the Minnesota Grown Cream of the Crop contest
It’s the cherry on top for schools and early care providers who serve up fresh, local food that fuels students, and supports ...
Cameco: Crashing Uranium Spot Price Points To Stagnant Income
Cameco’s Q4 earnings dropped 6.6% due to one-time charges and supply chain issues. Learn why CCJ stock’s future growth may be ...
Star of Mysore23h
Governor returns Mysuru Development Authority Bill
Thaawarchand Gehlot cites ongoing probes, pending Court cases in MUDA controversy Bengaluru: The State Government’s plan to ...